C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2002
10/22/2002	US6469006 Particularly for treating hiv infections
10/22/2002	US6469003 Pyridazinone derivatives
10/22/2002	US6469002 Compounds which modulate chemokine receptor activity and are useful in treatment of inflammatory diseases
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/17/2002	WO2002081735A2 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	WO2002081415A2 Method for inhibiting metap2
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002066468A3 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
10/17/2002	WO2002066456A3 Thiophene substituted amine derivatives as glyt-1 inhibitors
10/17/2002	WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002	WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002	WO2002026712A3 Quaternary amines and related inhibitors of factor xa
10/17/2002	WO2001083463A1 Oxadiazole derivatives having anticancer effects
10/17/2002	US20020151712 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
10/17/2002	US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002	US20020151555 Pyrimidine matrix metalloproteinase inhibitors
10/17/2002	US20020151553 Such as 4-(4-chlorophenyl)1-(3-(5-cyano-5H-dibenzo(a,d) cycloheptene-5-yl)propyl)piperidin-4-ol for treatment of diseases associated with aberrant leukocyte recruitment and/or activation
10/17/2002	US20020151539 Novel heterocyclic compounds
10/17/2002	CA2444024A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/16/2002	WO2001079201A1 Process for preparation of sulfonamide derivatives and crystals thereof
10/16/2002	EP1249450A1 Benzimidazole derivatives
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248779A2 Glycosidase ihhibitors and preparation thereof
10/16/2002	EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002	EP1248771A1 Method for preparing hydroxypicolinic acid derivatives
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	EP0641203B1 Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	CN1374995A Fluorescent maleimides and uses thereof
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1374959A Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374082A Use of glycogen sulphofoenzyme inhibitor
10/16/2002	CN1092655C 哌啶衍生物 Piperidine derivatives
10/16/2002	CN1092653C (4-piperidnyl)-1H-2-benzopyran derivatives used as antipsychotic agent
10/16/2002	CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002	CN1092639C Benzene-fused heterocyclic derivative and use thereof
10/16/2002	CA2406401A1 Process for preparation of sulfonamide derivatives and crystals thereof
10/15/2002	USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002	US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002	US6465495 Preparation of pyridone-based phosphotyrosine mimetics and uses thereof
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002	US6465484 Tyrosine kinase inhibitors; cancer, atherosclerosis, diabetic retinopathy, autoimmune diseases, inflammatory diseases
10/15/2002	US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002	US6465453 Azepine derivatives having effects on serotonin related systems
10/15/2002	US6465060 Tilted, smectic (ferroelectric) liquid crystals
10/15/2002	CA2256438C Aromatic amidine derivatives useful as selective thrombin inhibitors
10/15/2002	CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002	WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002	WO2002079199A1 Thiophene derivatives and use thereof
10/10/2002	WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002	WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002	WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002	WO2002079190A1 3-substituted indoles as chemokine antagonists
10/10/2002	WO2002079186A2 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002	WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079155A1 Pyrrolidine sulfonamides
10/10/2002	WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002	WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002	WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002078744A1 Remedies for psychoneurosis
10/10/2002	WO2002078707A1 Pyrrolidine sulfonamides
10/10/2002	WO2002078699A1 Compounds and methods
10/10/2002	WO2002078697A1 Compounds and methods
10/10/2002	WO2002078696A1 Compounds and methods
10/10/2002	WO2002078639A2 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002	WO2002078628A2 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
10/10/2002	WO2002050067A3 Pharmaceutical heterocyclic compounds
10/10/2002	WO2002006512A3 Method for detecting uracil biosynthesis inhibitors and their use as herbicides
10/10/2002	WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002	US20020147339 5-cyano-2-aminopyrimidine derivatives
10/10/2002	US20020147335 Anticancer, antitumor agents
10/10/2002	US20020147334 Vitronectin Receptor Antagonists
10/10/2002	US20020147231 Allosteric adenosine receptor modulators
10/10/2002	US20020147230 Cardiovascular disorders; antihistamines
10/10/2002	US20020147214 Enzyme inhibitors; anticancer agents
10/10/2002	US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002	US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002	US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002	US20020147188 Protease inhibitors
10/10/2002	US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/10/2002	US20020147181 Viricides
10/10/2002	DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002	CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002	CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	CA2442482A1 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002	CA2442455A1 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002	CA2442428A1 Novel tyrosine kinase inhibitors
10/10/2002	CA2441778A1 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002	CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002	CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same

1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 523